TD Cowen maintains American Well at Hold, raises price target to $13 from $12
TD Cowen kept American Well at Hold but raised its price target to $13 from $12, an 8.3% increase. This implies a 2.0% upside from the Nov 3 close of $12.74.
How this was made

The 30-second read
Why it matters
The price target increase signals confidence but is modest; market reaction may be muted.
Market read
A small analyst upgrade with a modest target raise; limited trading impact unless accompanied by further news.
What to watch
Potential competitive pressures and regulatory scrutiny in telehealth could limit upside.
Background
American Well (AMWL) is a telehealth platform that has been volatile; analyst coverage can influence short-term price moves.
Ticker impact
TD Cowen raised its price target for American Well to $13 from $12, indicating a modest upside.
likely modest upside as investors price in the higher target
The new target implies a 2% upside from the recent close, which may attract buying interest.
Market effects
Minor impact on the telehealth sector; analyst upgrades may lift peers.
U.S. market focus, no broader regional effect.
Limited to U.S. listed telehealth stocks.
Counterpoint
The target raise is modest and may already be priced in; investors could wait for stronger catalysts.
Key entities
- AnalystTD Cowen
Equity research firm that issued the rating and target change.
- CompanyAmerican Well
Telehealth services provider.


